Avidity Partners Management as of Dec. 31, 2024
Portfolio Holdings for Avidity Partners Management
Avidity Partners Management holds 62 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Dianthus Therapeutics (DNTH) | 6.2 | $63M | 2.9M | 21.80 | |
| Boston Scientific Corporation (BSX) | 4.5 | $46M | 515k | 89.32 | |
| Janux Therapeutics (JANX) | 3.9 | $40M | 742k | 53.54 | |
| Arvinas Ord (ARVN) | 3.9 | $40M | 2.1M | 19.17 | |
| Natera (NTRA) | 3.5 | $35M | 224k | 158.30 | |
| EXACT Sciences Corporation (EXAS) | 3.3 | $34M | 603k | 56.19 | |
| Intuitive Surgical Com New (ISRG) | 3.3 | $34M | 65k | 521.96 | |
| Cg Oncology (CGON) | 3.1 | $32M | 1.1M | 28.68 | |
| UnitedHealth (UNH) | 3.0 | $30M | 60k | 505.86 | |
| Neurocrine Biosciences (NBIX) | 3.0 | $30M | 220k | 136.50 | |
| Ideaya Biosciences (IDYA) | 2.8 | $29M | 1.1M | 25.70 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 2.8 | $29M | 235k | 123.15 | |
| Mirum Pharmaceuticals (MIRM) | 2.7 | $28M | 666k | 41.35 | |
| Acadia Healthcare (ACHC) | 2.6 | $26M | 658k | 39.65 | |
| Glaukos (GKOS) | 2.5 | $26M | 170k | 149.94 | |
| Dex (DXCM) | 2.4 | $25M | 318k | 77.77 | |
| Thermo Fisher Scientific (TMO) | 2.3 | $23M | 45k | 520.23 | |
| Humana (HUM) | 2.2 | $23M | 89k | 253.71 | |
| Kymera Therapeutics (KYMR) | 2.0 | $20M | 500k | 40.23 | |
| Avantor (AVTR) | 2.0 | $20M | 947k | 21.07 | |
| Syndax Pharmaceuticals (SNDX) | 1.9 | $20M | 1.5M | 13.22 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 1.9 | $20M | 1.2M | 16.75 | |
| Revolution Medicines (RVMD) | 1.9 | $20M | 446k | 43.74 | |
| Xenon Pharmaceuticals (XENE) | 1.8 | $19M | 474k | 39.20 | |
| Tenet Healthcare Corp Com New (THC) | 1.7 | $17M | 137k | 126.23 | |
| Insmed Com Par $.01 (INSM) | 1.6 | $16M | 233k | 69.04 | |
| Axsome Therapeutics (AXSM) | 1.6 | $16M | 188k | 84.61 | |
| Blueprint Medicines (BPMC) | 1.5 | $15M | 177k | 87.22 | |
| Danaher Corporation (DHR) | 1.5 | $15M | 67k | 229.55 | |
| Ultragenyx Pharmaceutical (RARE) | 1.5 | $15M | 352k | 42.07 | |
| Illumina (ILMN) | 1.4 | $15M | 110k | 133.63 | |
| Abbvie (ABBV) | 1.4 | $14M | 81k | 177.70 | |
| Rocket Pharmaceuticals (RCKT) | 1.3 | $13M | 1.1M | 12.57 | |
| Bristol Myers Squibb (BMY) | 1.2 | $12M | 215k | 56.56 | |
| Transmedics Group (TMDX) | 1.2 | $12M | 192k | 62.35 | |
| Phathom Pharmaceuticals (PHAT) | 1.1 | $11M | 1.4M | 8.12 | |
| Surgery Partners (SGRY) | 1.1 | $11M | 514k | 21.17 | |
| Oric Pharmaceuticals (ORIC) | 1.0 | $10M | 1.3M | 8.07 | |
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 0.9 | $9.1M | 354k | 25.70 | |
| Incyte Corporation (INCY) | 0.9 | $9.0M | 130k | 69.07 | |
| Perspective Therapeutics Com New (CATX) | 0.8 | $8.6M | 2.7M | 3.19 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 0.8 | $8.5M | 62k | 137.67 | |
| Biohaven (BHVN) | 0.8 | $8.3M | 223k | 37.35 | |
| Intra Cellular Therapies (ITCI) | 0.8 | $8.1M | 97k | 83.52 | |
| Immunic (IMUX) | 0.8 | $8.0M | 8.0M | 1.00 | |
| Context Therapeutics (CNTX) | 0.8 | $7.9M | 7.5M | 1.05 | |
| Oruka Therapeutics (ORKA) | 0.7 | $6.8M | 352k | 19.39 | |
| Regeneron Pharmaceuticals (REGN) | 0.6 | $6.0M | 8.4k | 712.33 | |
| Bruker Corporation (BRKR) | 0.4 | $4.5M | 76k | 58.62 | |
| Vera Therapeutics Cl A (VERA) | 0.4 | $4.2M | 100k | 42.29 | |
| Regenxbio Inc equity us cm (RGNX) | 0.4 | $4.1M | 532k | 7.73 | |
| Uniqure Nv SHS (QURE) | 0.4 | $3.9M | 222k | 17.66 | |
| Kezar Life Sciences Com New (KZR) | 0.3 | $3.4M | 503k | 6.72 | |
| Keros Therapeutics (KROS) | 0.3 | $3.3M | 210k | 15.83 | |
| Akero Therapeutics (AKRO) | 0.2 | $2.3M | 82k | 27.82 | |
| Dyne Therapeutics (DYN) | 0.2 | $2.3M | 96k | 23.56 | |
| Cogent Biosciences (COGT) | 0.2 | $2.2M | 287k | 7.80 | |
| Neumora Therapeutics Call Option (NMRA) | 0.2 | $1.6M | 150k | 10.60 | |
| Scynexis Com New (SCYX) | 0.1 | $1.5M | 1.2M | 1.21 | |
| Karyopharm Therapeutics | 0.1 | $1.4M | 2.0M | 0.68 | |
| Hyperfine Com Cl A (HYPR) | 0.1 | $1.0M | 1.2M | 0.88 | |
| Bluebird Bio Com New | 0.1 | $680k | 82k | 8.34 |